HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Winai Ratanasuwan Selected Research

Emtricitabine (Emtriva)

1/2018Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial.
11/2017Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Winai Ratanasuwan Research Topics

Disease

9Infections
09/2022 - 10/2007
6HIV Infections (HIV Infection)
01/2016 - 03/2003
4Coinfection
11/2017 - 09/2013
3Hepatitis B
01/2018 - 01/2016
3Acquired Immunodeficiency Syndrome (AIDS)
01/2017 - 02/2004
3Hepatitis C
01/2016 - 01/2014
2Body Weight (Weight, Body)
01/2023 - 06/2019
2Opportunistic Infections (Opportunistic Infection)
01/2015 - 02/2004
1Proteinuria
01/2023
1COVID-19
09/2022
1Cognitive Dysfunction
01/2019
1Bacterial Infections (Bacterial Infection)
01/2019
1Malaria
01/2019
1Pneumonia (Pneumonitis)
01/2019
1Tuberculosis (Tuberculoses)
01/2019
1Anemia
01/2017
1Inflammation (Inflammations)
01/2016
1Hyperglycemia
10/2012
1Hypoglycemia (Reactive Hypoglycemia)
10/2012
1Exanthema (Rash)
01/2012
1Nausea
11/2009
1Dizziness (Lightheadedness)
11/2009
1Headache (Headaches)
11/2009
1Viremia
06/2004
1Hepatitis A (Hepatitis, Infectious)
06/2004
1Cerebral Toxoplasmosis
02/2004
1Cryptococcosis
02/2004
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
02/2004

Drug/Important Bio-Agent (IBA)

6Tenofovir (Viread)FDA Link
01/2023 - 01/2014
5RNA (Ribonucleic Acid)IBA
01/2018 - 06/2004
5Raltegravir PotassiumFDA Link
01/2018 - 10/2007
3NucleosidesIBA
01/2013 - 06/2004
2Emtricitabine (Emtriva)FDA Link
01/2018 - 11/2017
2Stavudine (Zerit)FDA LinkGeneric
01/2014 - 06/2004
2Reverse Transcriptase InhibitorsIBA
01/2013 - 04/2008
1LipidsIBA
01/2023
1VaccinesIBA
09/2022
1CobicistatIBA
06/2019
1elvitegravirIBA
06/2019
1emtricitabine tenofovir alafenamideIBA
06/2019
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2019
1Antiviral Agents (Antivirals)IBA
03/2016
1N- (5- (1- methyl- 1H- pyrazol- 4- yl)- napthalene- 2- carbonyl)guanidineIBA
03/2016
1Alanine Transaminase (SGPT)IBA
01/2016
1Lamivudine (Epivir)FDA Link
09/2013
1Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2013
1Insulin (Novolin)FDA Link
10/2012
1Nevirapine (Viramune)FDA Link
01/2012
1efavirenz (Sustiva)FDA Link
11/2009
1Protease Inhibitors (Protease Inhibitor)IBA
04/2008
1Human immunodeficiency virus 1 p31 integrase proteinIBA
10/2007
1Hepatitis A AntibodiesIBA
06/2004
1CytokinesIBA
03/2003

Therapy/Procedure

7Therapeutics
01/2019 - 06/2004
3Art Therapy
01/2016 - 01/2012
1Polypharmacy
01/2019
1Highly Active Antiretroviral Therapy (HAART)
09/2012
1Chemoprevention
02/2004
1Secondary Prevention
02/2004